HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kevin R Fales Selected Research

N1- (4- (3- isopropyl- 2- methylindazol- 5- yl)pyrimidin- 2- yl)- N4- tetrahydropyran- 4- yl- cyclohexane- 1,4- diamine

6/2014A novel CDK9 inhibitor shows potent antitumor efficacy in preclinical hematologic tumor models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kevin R Fales Research Topics

Disease

3Neoplasms (Cancer)
10/2018 - 06/2014
1Leukemia
06/2014

Drug/Important Bio-Agent (IBA)

2AICA ribonucleotide (ZMP)IBA
10/2018 - 12/2017
2purineIBA
10/2018 - 12/2017
2Folic Acid (Vitamin M)FDA LinkGeneric
10/2018 - 12/2017
1Folic Acid AntagonistsIBA
12/2017
1Hydroxymethyl and Formyl TransferasesIBA
12/2017
1pyrimidineIBA
12/2017
14-aminoimidazoleIBA
12/2017
1DNA (Deoxyribonucleic Acid)IBA
12/2017
1EnzymesIBA
12/2017
1RibonucleotidesIBA
12/2017
1RNA (Ribonucleic Acid)IBA
12/2017
1SulfonamidesIBA
12/2017
1ThiophenesIBA
12/2017
1Phosphotransferases (Kinase)IBA
06/2014
1Proteins (Proteins, Gene)FDA Link
06/2014
1N1- (4- (3- isopropyl- 2- methylindazol- 5- yl)pyrimidin- 2- yl)- N4- tetrahydropyran- 4- yl- cyclohexane- 1,4- diamineIBA
06/2014

Therapy/Procedure

1Oral Administration
10/2018